Bahamas STEM News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Bahamas STEM News.

Press releases published on November 12, 2026

Nov. 12, 2026

IMUNON Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 12, 2026

Aktis Oncology Reports Third-Quarter Financial Results and Highlights Clinical Trial Progress

Indeterminate GlobeNewswire

Nov. 12, 2026

Kyverna Therapeutics Announces Completion of BLA Submission for Miv-cel in Stiff Person Syndrome and Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 12, 2026

Monopar Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

Nov. 12, 2026

Randomized Study of Non-Invasive Autonomic Neuromodulation for Long COVID Published Online in Neuromodulation

Indeterminate GlobeNewswire

Nov. 12, 2026

EagleNXT Secures Drone Orders Across Seven Countries in One Week

Indeterminate GlobeNewswire

Nov. 12, 2026

Vivani Medical Announces Positive Top-Line Results from SLIM-1™, a First in Human Phase 1 Trial of NPM-139 (semaglutide implant) and Wegovy (weekly semaglutide injections) in Obese and Overweight Subjects

Indeterminate GlobeNewswire

Nov. 12, 2026

Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference 2026 in London

Indeterminate GlobeNewswire

Nov. 12, 2026

BTCS Reports Record Gross Profit of $3.5 Million and 86% Gross Margin for Third Quarter 2026

Indeterminate GlobeNewswire

Nov. 12, 2026

SecureAuth Introduces Agent Checkpoints for Agentic AI Workflows

Indeterminate GlobeNewswire

Nov. 12, 2026

Fort Technology Enters into Credit Facility Agreements for Up to $20 Million to Support its Data Center and E-Commerce Activities

Indeterminate GlobeNewswire

Nov. 12, 2026

Intuitive Machines Reports Third Quarter 2026 Financial Results; Reports Record Financials Across The Board - Revenue, Profitability, Positive Cash Flow, and Backlog

Indeterminate GlobeNewswire

Nov. 12, 2026

Biolojic Design Receives U.S. FDA Clearance of Investigational New Drug (IND) Application for BD200, the First Multibody to Enter Clinical Trials

Indeterminate GlobeNewswire

Nov. 12, 2026

Sagimet Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

Nov. 12, 2026

Profusa Announces Progress Towards Satisfying the Conditions to Close of the Option Agreement with G3

Indeterminate GlobeNewswire

Nov. 12, 2026

Aclaris Therapeutics to Participate in the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

Nov. 12, 2026

Taysha Gene Therapies Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Nov. 12, 2026

Altimmune Announces Third Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire

Nov. 12, 2026

Cerenome to Review REYOBIQ ReSPECT-LM Data Presented at SNO Conference and Provide CNSide Commercial Update on November 16

Indeterminate GlobeNewswire

Nov. 12, 2026

Immuneering Announces New Potentially Registrational Phase 2 Trial Evaluating Atebimetinib with Chemotherapy in Anaplastic Thyroid Cancer

Indeterminate GlobeNewswire